A noncytotoxic protein substance, produced by Streptococcus intermedius, with very potent immunosuppressive properties (F3'EP-Si) was tested for lymphocyte mitogenic activity. Although devoid of T-cell mitogenicity, F3'EP-Si stimulated proliferation and led to high numbers of plaque-forming cells in cultures of normal or T-cell-depleted, small or large splenic B cells from both lipopolysaccharide-responding and -nonresponding mice. The B-cell mitogenic activity of F3'EP-Si was quantitatively comparable to that of lipopolysaccharide, and the simultaneous exposure to both mitogens stimulated additive B-cell responses. Injection of F3'EP-Si into normal mice resulted in increased numbers of spleen cells, higher rates of mitotic activity, and very large numbers of plaque-forming cells, predominantly of the immunoglobulin G2a and -b isotypes. In preliminary experiments, the analysis of surface markers among the lymphocytes participating in the blastogenic response in vivo revealed a T-cell component in the response to F3'EP-Si. These observations are discussed in the context of the immunosuppressive activity of this and other microbial substances.
We previously observed (3, 4 ) that a protein secreted by Streptococcus intermedius (F3'EP-Si) is a potent suppressive substance against the in vitro proliferative responses of human peripheral blood mononuclear cells and against the in vivo primary antibody response of C57BL/6 mice to sheep erythrocytes. Two observations led us to assume that the immunosuppression by F3'EP-Si was mediated by a pathway of overstimulation or excessive help and subsequent generation of T suppressor lymphocytes (3): (i) the suppressive effect of F3'EP-Si was more evident when the protein was tested under conditions favorable for reactivity and maturity of the target system, and (ii) the effects of F3'EP-Si in immune responses could be switched from suppressive to stimulatory when the time of exposure or target system or both were reduced, even under conditions of weak stimulation. This assumption was substantiated by the fact that F3'EP-Si-treated animals exhibited splenomegaly with histological patterns consistent with an adjuvantlike effect (5) .
Because it had been demonstrated that other microorganisms, including Brucella melitensis (22) , Leishmania spp. (21) , Trypanosoma cruzi (13; P. Minoprio, H. Eisen, L. Forni, R. Imperio-Lima, M. Joskwicz, and A. Coutinho, submitted for publication), and lactic dehydrogenase virus (7) , are B-cell mitogens, we decided to investigate whether F3'EP-Si was also a B-cell mitogen, which could explain the observed stimulatory immunosuppressive effects of this substance. We report here results demonstrating strong B-cell mitogenicity in vitro and in vivo which, in preliminary experiments, appeared to result in the secondary participation of T lymphocytes.
MATERIALS AND METHODS
Preparation of F3'EP-Si. F3'EP-Si was prepared as previously described (3) (4) (5) . Briefly, S. intermedius was cultured * Corresponding author.
anaerobically over a dialysis membrane in close contact with tryptone-glucose agar culture medium for 24 h at 37°C. The dialysis membranes were then washed with 0.05 M potassium phosphate buffer, and the wash was clarified by ultracentrifugation and concentrated by vacuum dialysis. F3'EP-Si was then obtained out of crude material by preparative isoelectrofocusing in a sucrose gradient, and its biological activity was evaluated by its ability to inhibit the primary immune response of C57BL/6 mice against sheep erythrocytes when injected into the animals 2 days before immunization. A unit of biological activity (UBA) was defined as the dose of F3'EP-Si that reduced by 50% the numbers of directly hemolytic splenic plaque-forming cells (PFCs) of treated animals. All preparations of the substance were sterilized by irradiation and diluted in balanced salt solution before use in tissue culture.
Mice. C57BL/6, C57BL/lOSrCr, C3H/He, C3H/Tif, and A/J mice were bred at the Pasteur Institute.
Cell preparation and culture. Spleen cells were prepared in single suspension as previously described (1). T-cell removal was achieved by cytotoxicity with the monoclonal rat antimouse Thy-1 antibody J.lj (,u and K chains) (kindly provided by J. Sprent, Scripps Clinic and Research Foundation, La Jolla, Calif.) and rabbit complement. T-cell enrichment was obtained by passage over nylon-wool columns (14) , with cell yields varying from 15 to 20%. Isolation of small and large splenic lymphocytes was performed on discontinuous Percoll gradients as described previously (16, 17 (Fig. 1) .
(ii) F3'EP-Si is a murine B-cell mitogen. To evaluate whether the lymphocyte mitogenic activity described above, which appeared to include B lymphocytes, was dependent on or encompassed T cells as well, a purified preparation of F3'EP-Si was titrated on T-cell-depleted spleen cell cultures in parallel with cultures of untreated cells. There was little or no difference in the proliferative and PFC responses of biotics, as described previously (1) . The cultures were set up in 0.2-ml portions in the wells of microtiter plates and incubated at 37°C in a humidified atmosphere of 5% CO2 in air.
Mitogens. Lipopolysaccharide (LPS) from "Streptococcus abortus subsp. equi" was obtained from Difco Laboratories, Detroit, Mich., and ConA was obtained from Pharmacia, Uppsala, Sweden.
Assays. Proliferative responses were assayed by incorporation of tritiated thymidine (specific activity, 2 Ci/mmol; Amersham, England) after a 3-h pulse with 1 ,uCi per culture. Polyclonal B-lymphocyte responses were quantitated by the numbers of high-rate immunoglobulin-secreting cells detected as PFCs in the protein A assay (12) . Rabbit antisera specific for each isotype of the mouse immunoglobulins used as developing antibodies in the plaque assay have been characterized (8) . In each experiment, all assays were done in triplicate cultures, and the results are expressed as mean values. For simplicity, the standard errors of the means are not shown because in every case they were less than 15% of the mean.
Dual-parameter analysis of cell size and surface markers was performed by flow cytofluorometry with an FACS Analyzer I (Becton Dickinson and Co., Paramus, N.J.) and the following monoclonal antibodies: rat anti-mouse K chains [R33-18; immunoglobulin G (IgG)(K) (R. Grutzmann, Ph.D. thesis, University of Cologne, Cologne, Federal Republic of Germany, 1981)], rat anti-Lyt-2 [53-6.7; IgG(K) (15) ], and rat anti-L3T4 [H-129.19.69; IgG(K) (19) ]. These were biotinylated as described previously (10), and surface stainings with avidin-fluorescein were performed as previously described (10) . (Fig. 2) . The same was true for the control responses to LPS, whereas T-cell-depleted cultures failed to develop proliferative responses to the T-lymphocyte mitogen ConA (data not shown).
Independent confirmation for the lack of direct effects of F3'EP-Si on normal T cells was obtained in experiments in which T-cell-enriched preparations were cultured with a wide range of concentrations of the substance in the presence or absence of IL-2-containing conditioned medium (Table 1) . We conclude, therefore, that F3'EP-Si is a strong B-lymphocyte mitogen and appears devoid of direct mitogenic or otherwise stimulatory effects on T lymphocytes. In an attempt to further characterize the target B cells in terms of the mitogenic activity of F3'EP-Si, we analyzed the responses of small and large spleen cells, since B-cell mitogens with activity limited to large, previously induced cells have been described (2) . However, F3'EP-Si showed comparable activating properties for both large and small B lymphocytes from a normal murine spleen (Fig. 3) .
(iii) F3'EP-Si is a B-lymphocyte mitogen for a cell population different from those responding to LPS. Because the activity of F3'EP-Si is qualitatively and quantitatively very similar to that of LPS, putative contaminations with this well-characterized mitogen should be controlled. C57BL/lOScCr mice carry a defective allele at the lps locus in chromosome 4 (9) which results in a complete lack of reactivity to this mitogen and invariably diminished responses to other B-cell activators. However, C57BL/lOScCr B cells proliferate and differentiate to PFCs if stimulated by F3'EP-Si at levels which are comparable to those observed in C57BL/6 mice (Fig. 4) . In contrast, LPS-induced responses are excellent in C57BL/6 mice and completely absent in C57BL/1OScCr spleen cells. We conclude that the B-cell mitogenic activity of F3'EP-Si is not due to contamination by LPS-like substances.
An alternative evaluation of the contribution of LPS to the polyclonal responses to F3'EP-Si was provided by mixing experiments. Titrating LPS to find the concentrations inducing optimal proliferation and adding various F3'EP-Si preparations to near optimal concentrations of LPS allowed us to determine whether the mitogenic activity of the latter is effected via the same or similar mitogenic principles. Thus, assuming that all LPS-reactive lymphocytes were already responding to optimal LPS concentrations, the finding of additive effects in the response to mixtures of LPS and F3'EP-Si would provide strong indications for additional lymphocytes being activated by mitogenic substances other than LPS. This was in fact the case for five independently prepared batches of F3'EP-Si tested by this protocol (Fig. 5) . In every case, clear additive effects were observed which, in addition to demonstrating the nondependence of F3'EP-Si mitogenicity on LPS, suggest, very interestingly, that this particular substance stimulates B-lymphocyte populations that are largely different from those responding to LPS.
In vivo experiments: mitogenicity of F3'EP-Si blastogenesis of B and T cells and restricted isotype pattern of PFCs. The mitogenic effects of F3'EP-Si detected in vitro would have greater significance for the interpretation of the suppressive effects previously described (3-5) if they were observ6d in vivo as well.
Normal C3H mice were injected with F3'EP-Si, and 4 days later, various parameters of lymphoid activity in their spleens were analyzed in parallel with activity in control mice treated with saline. Injection of F3'EP-Si resulted in hypercellularity and in increased in vivo mitotic activity in the spleens (Table 2) . Most importantly, a considerable increase in the numbers of total PFCs was detected in the spleens, demonstrating the B-cell mitogenicity of F3'EP-Si in vivo. It is interesting to note the isotype specificity of this polyclonal B-cell response in vivo. It has been shown (6) mice to a thymus-dependent antigen (3). More recently, we also observed very significant prolongations of skin graft survival in murine allogenic combinations as a result of systemic administration of F3'EP-Si (M. Arala Chaves, unpublished observations). As explicated above, some characteristics of F3'EP-Si action suggested the possibility that the suppression of the immune response induced subsequent to its administration could come about by a mechanism of excessive stimulation of the participating lymphocytes and subsequent generation of suppressor T lymphocytes (5) .
As shown here by the study of purified lymphocyte populations, F3'EP-Si is a B-cell mitogen, but it displays no detectable, direct stimulatory properties for T lymphocytes in vitro. This might explain why we have not observed a macrophage-dependent immunosuppressor effect of F3'EPSi (3), an effect that would be expected, unlike B-cell mitogenicity, if F3'EP-Si was primarily affecting T lymphocytes. Furthermore, F3'EP-Si was a competent mitogen for B cells from LPS-nonresponding mice, which excludes the possibility that its functional properties were due to endotoxin contamination in our preparations. Interestingly, B-cell responses to the simultaneous stimulation with F3'EP-Si and LPS stimulated largely distinct B-lymphocyte subpopulations. Similar observations have been reported for LPS, purified protein derivative, and dextran sulfate and interpreted as an indication of selective mitogen reactivity of B cells according to their differentiative stages (11) .
It is important to emphasize that the mitogenic activity of F3'EP-Si was readily demonstrable in vivo under the same conditions as those which result in immunosuppression of immune responses. This lends further support to the hypothesis that these two immunological consequences of F3'EPSi injection are interrelated.
Because in the latter case this peculiar isotype pattern was attributed to T-cell participation in the response, we investigated this possibility by studying the state of activation of T lymphocytes in the spleens of F3'EP-Si-injected mice. This was done by flow cytofluorometry by using cell volume as a parameter of blastogenic activity and performing dualparameter analysis for T-cell-specific surface markers (Fig. 6 and Table 3 ). Injection of F3'EP-Si resulted 4 days later in a considerable increase in the total number of spleen cells and, more importantly, in the frequency of activated, large cells. The analysis of each lymphocyte population distinguished by surface markers confirmed that a blastogenic response of B cells took place and, in addition, revealed a notorious T-lymphocyte response in both the L3T4 (helper) and Lyt-2 (suppressor) compartments. The latter was clearly more stimulated than was the helper-inducer subpopulation.
These results established that F3'EP-Si stimulates in vivo a considerable number of B and T cells to blast transformation and increases mitotic activity under the same conditions as those which result in strong immunosuppression. (7) . A large blastogenic B-cell response is followed by a stage of extensive T-lymphocyte activation (20) . Reinforcing this parallel, it is interesting that the predominant classes of immunoglobulin in the polyclonal B-cell response to T. cruzi infection are the IgG2a and IgG2b isotypes (13) , which are relatively T-cell dependent (8) and precisely the dominant isotypes which occur in response to F3'EP-Si, as shown here.
Underlying all of these questions, there is a most interesting possibility that different microorganisms can induce the generation of T suppressor cells and thus immunosuppression through polyclonal B-cell activation; it was recently described for leishmaniasis (21) that B-cell activation can induce T-cell suppression.
